AF
ABUS icon

Allworth Financial’s Arbutus Biopharma ABUS Stock Holding History

Allworth Financial’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.27K Buy
2,060
+17
+0.8% +$74 ﹤0.01% 3556
2025
Q4 		$9.83K Buy
2,043
+1,928
+1,677% +$8.67K ﹤0.01% 3278
2025
Q3 		$523 Sell
115
-304
-73% -$1.12K ﹤0.01% 4425
2025
Q2 		$1.29K Sell
419
-258
-38% -$857 ﹤0.01% 3885
2025
Q1 		$2.26K Buy
+677
New +$2.26K ﹤0.01% 3165
2023
Q3 		– Sell
-440
Closed -$1.01K – 3432
2023
Q2 		$1.01K Hold
440
– – ﹤0.01% 2732
2023
Q1 		$1.33K Hold
440
– – ﹤0.01% 2562
2022
Q4 		$1.02K Buy
+440
New +$1.05K ﹤0.01% 2468

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return